Health Condition 1: L639- Alopecia areata, unspecified
Conditions
Interventions
Intervention1: Patients of AA will receive Intralesional Platelet rich fibrin: Half of the patches of AA will receive intralesional injections of platelet rich fibrin prepared in
departmental lab.
Pre
Sponsors
Dr RPGMC Tanda
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of AA between Age group 18 to 50 years. 2. Diagnosed clinically with alopecia areata of scalp coming to skin opd. 3. Patients willing to give consent for inclusion in study 4. Patients who have not taken medical treatment for AA in any form for the last 6 months. 5. Control group includes age and sex matched individuals without history of AA 6. Platelet count more than 1.5 lac
Exclusion criteria
Exclusion criteria: 1. Patients with alopecia other than alopecia areata. 2. Patients with active infection at the local site. 3. Patients having keloidal tendency. 4. Patients with blood coagulopathies. 5. Platelet count less than 1.5 lacs per l. 6. Patients who are immunosuppressed (HIV, malignancy, steroid or chemotherapy). 7. Pregnancy or lactation 8. Patients not willing to give written informed consent. 9. Patient on anticoagulation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Investigator assessment scaleTimepoint: Baseline, 2, 4, 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Trichoscopic Analysis 1 Size of alopecia patch using measuring tape 2 Location Of alopecia patchTimepoint: Baseline, 2, 4, 6 months;Patients self-assessmentTimepoint: Baseline, 2, 4, 6 months;Improvement assessment based on SALT scoreTimepoint: Baseline, 2, 4, 6 months | — |
Countries
India
Contacts
Public ContactDr Deepak soan
Department of DVL, Dr RPGMC Tanda
Outcome results
None listed